
- Vol 42, Issue 5
The Dawn of a New Era for Schizophrenia
Key Takeaways
- Schizophrenia affects 24 million people worldwide, with stigma impacting up to 64.5% of those diagnosed.
- Psychiatrists' perceptions of violence in schizophrenia contribute to diagnostic bias and stigma.
Learn more about the latest advancements in schizophrenia treatment and the ongoing battle against stigma during Mental Health Awareness Month.
May is Mental Health Awareness Month, and the 24th is World Schizophrenia Awareness Day. Latest figures show that worldwide, approximately 24 million individuals are affected by
Simultaneously, however, we are on the cusp of a bright new era for schizophrenia treatment. Last year saw the approval of xanomeline and trospium chloride (Cobenfy), the first new agent for schizophrenia with a novel mechanism of action in more than 50 years.4 Investigators are also exploring new alternatives, such as genetic models and synapse regeneration.5,6 These could represent the next big breakthrough or perhaps stepping stones for even further development.
We must work together to defeat bias, formulate new treatment options, and improve patient outcomes for individuals with schizophrenia. To help you stay on top of the latest views, we have compiled a collection of expert-written articles focused exclusively on schizophrenia in this month’s Special Report. As always, we endeavor to remain your go-to resource. If there are any topics you would like to see more on, write to us at
Mike Hennessy Jr
President and CEO, MJH Life Sciences
References
1. Schizophrenia. World Health Organization. January 10, 2022. Accessed April 8, 2025.
2. Gerlinger G, Hauser M, De Hert M, et al.
3. Clark T, Rowe R.
4. Duerr HA. FDA approves Cobenfy, a first-in-class agent for schizophrenia. Psychiatric Times. September 26, 2024.
5. Duerr HA, Kosten TR. Exploring genetic models in schizophrenia research: a teaser from ACNP annual meeting. Psychiatric Times. December 10, 2024.
6. Kuntz L. Phase 2 trial open enrollment for SPG302, first synaptic regenerative approach to treat schizophrenia. Psychiatric Times. March 31, 2025.
Articles in this issue
5 months ago
"Transference"5 months ago
The Double-Edged Sword of AffluenceNewsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.